Mateon Therapeutics Inc. buy klostergang
Start price
03.06.15
/
50%
€1.36
Target price
07.12.15
€1.70
Performance (%)
-39.82%
End price
07.12.15
€0.82
Summary
This prediction ended on 07.12.15 with a price of €0.82. The BUY prediction by klostergang for Mateon Therapeutics Inc. performed very badly with a performance of -39.82%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Mateon Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0,85 % | 1,37 % | 2,61 % | 52,29 % |
| iShares Nasdaq 100 | -0,99 % | -3,84 % | 25,55 % | 78,88 % |
| iShares Nikkei 225® | -1,78 % | -8,53 % | 42,81 % | 65,51 % |
| iShares S&P 500 | 0,06 % | 0,61 % | 21,57 % | 63,55 % |
Comments by klostergang for this prediction
In the thread Mateon Therapeutics Inc. diskutieren
Die FDA billigt PFS als primären Endpunkt der Phase-3-Studie :
http://seekingalpha.com/article/3228966-there-is-significant-upside-ahead-for-oxigene
(Vom Mitglied beendet)